Search filters

List of works by Patrice Viens

A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study.

scientific article

A seven-gene prognostic model for platinum-treated ovarian carcinomas ⬇️

scientific article published on June 7, 2011

A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor

scientific article

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

scientific article published on 18 October 2013

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

scientific article

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

scientific article

Assessment of prognostic scores in brain metastases from breast cancer.

scientific article published on 04 December 2013

Association of carcinoid tumor and low grade glioma ⬇️

scientific article published on November 8, 2012

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

scientific article published on 05 July 2012

BetaHCG secretion by a pulmonary adenocarcinoma.

scientific article published on 14 September 2013

Bevacizumab in HER2-negative inflammatory breast cancer

scientific article published on 15 November 2016

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.

scientific article published on 28 March 2016

Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups.

scientific article published on March 2012

Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling

scientific article published on 09 January 2014

Carcinomatous myelitis and meningitis after a squamous cell carcinoma of the lip.

scientific article published on 16 January 2014

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

scientific article published on 12 April 2018

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizuma

scientific article published in January 2017

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

scientific article

Clinical development of mTOR inhibitors in breast cancer

scientific article published on 17 February 2014

Comparative genomic analysis of primary tumors and metastases in breast cancer.

scientific article published on 25 March 2016

Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer

scientific article

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

scientific article published on 24 September 2016

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

scientific article published on 08 June 2011

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

article

Difference in therapeutic response between basal and nonbasal triple-negative breast cancers.

scientific article published on 19 August 2013

Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

scientific article

Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients.

scientific article

EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer

scientific article published on 10 September 2014

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival

scientific article published on 02 December 2013

Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.

scientific article

Genomic and expression analysis of microdissected inflammatory breast cancer

scientific article published on 9 April 2013

Genomic profiling of inflammatory breast cancer: a review.

scientific article published on 04 July 2014

Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.

scientific article published on 06 June 2016

High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes

scientific article

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

scientific article published on 4 April 2016

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

scientific article published on 16 January 2017

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

scientific article

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.

scientific article published on 14 October 2015

Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience

scientific article published on 14 February 2017

Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer.

scientific article

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

scientific article

Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.

scientific article

Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature.

scientific article

MARCKS protein overexpression in inflammatory breast cancer

scientific article published on 21 December 2016

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.

scientific article

Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France.

scientific article published in February 2017

Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.

scientific article published on July 2012

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

scientific article

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

scientific article published on 28 February 2012

Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106).

scientific article published on 11 May 2017

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.

scientific article published on February 2016

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer

scientific article published on 11 May 2015

Participants' uptake of clinical trial results: a randomised experiment.

scientific article

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

scientific article published on 23 December 2014

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

scientific article

Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation

scientific article published on 01 January 2010

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.

scientific article published on 11 November 2010

Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer

scientific article published on 18 November 2010

Prescribers' attitudes toward elderly breast cancer patients. Discrimination or empathy?

scientific article published on 23 October 2009

Prognostic and predictive value of PDL1 expression in breast cancer

scientific article published on March 2015

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.

scientific article published on June 2015

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

scientific article published on 23 October 2016

Prognostic impact of the combination of erythropoiesis-stimulating agents to cancer treatment: literature review.

scientific article published on 18 June 2013

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

scientific article published on 04 July 2011

Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.

scientific article published in November 2010

SPAG5: the ultimate marker of proliferation in early breast cancer?

scientific article published on 14 June 2016

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.

scientific article published on 28 December 2017

Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer

scientific article published on 22 November 2017

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.

scientific article published on 31 July 2017

Sport coaching for psychological and social recovery after hematological cancer: An innovative perspective

scientific article published on 11 October 2017

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

scientific article published on 06 May 2019

Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies: the French experience.

scientific article

Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes ⬇️

scientific article published on November 9, 2011

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study

scientific article published on 18 October 2016

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

scientific article published on 24 October 2018

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

scientific article published on 16 May 2017

Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma

scientific article published on 9 March 2015

Transparency in the presentation of trial results may not increase patients' trust in medical researchers.

scientific article

Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancer

scientific article

UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.

scientific article published on 05 May 2015

Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets

scientific article published on 8 February 2013

Young breast cancer patients' involvement in treatment decisions: the major role played by decision-making about surgery.

scientific article published on 7 June 2013

[Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival]

scientific article published on 22 April 2011

[Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers]

scientific article published on 01 March 2010

[Systemic treatments of inflammatory breast cancer: an overview].

scientific article published in December 2014

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

scientific article published in May 2013

Paulina is supported by:

About Paulina

Help